Skip to main content
OpenTrials
Completed

NCT Number: NCT04748965

Imaging-Guided Vessel Sizing in the Tibial Arteries

This study aims to investigate the utilization of intravascular imaging in treatment of tibial vessels in peripheral artery disease and critical limb ischemia (CLI). The primary goal is to compare optical coherence tomography (OCT) with traditional digital subtraction angiography (DSA) in determining best treatment strategy and vessel optimization, in an effort to improve long term patency and successful wound healing in CLI. Secondary comparison with intravascular ultrasound (IVUS) is undertaken when clinically feasible. The hypothesis is that the adjunctive use of intravascular imaging will affect vessel sizing and anticipated treatment modalities, and therein affect the long term primary patency rates.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospitals Ahuja Medical Center, Beachwood, Ohio, United States

Loading trial locations.

About this study

This is a prospective, nonrandomized trial to investigate the adjunctive use of intravascular imaging in tibial vessel interventions. The evaluation of OCT is primarily to: (a) establish feasibility and reproducibility in below-the-knee vessels, (b) determine the optimal protocol imaging to produce the optimal clear image frame and clear image length, (c) provide detailed lesion characteristics of tibial disease, (d) assess for luminal gain post-intervention. Operator-determined sizing will be compared against University Hospitals Core Imaging Laboratory assessment of OCT, IVUS (when applicable), and quantitative vessel analysis (QVA).

Subjects will follow up per routine care with corresponding ankle-brachial index and toe-brachial index at 1, 3, 6, and 12 months or as clinically indicated. Wound and amputation data will be collected at the pre-procedural visit and with each subsequent visit. Wound care will be managed by our wound care associates in podiatry, vascular medicine, vascular surgery, or plastic surgery.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age >18
  • Patients with presence of Rutherford IV-VI
  • Presence of ≥1 tibial artery involvement requiring endovascular treatment

Exclusion criteria

  • Patients who do not have tibial disease appropriate for intervention
  • Estimated glomerular filtration rate <30 mL/min not on hemodialysis

Treatment and study plan

Digital Subtraction Angiography

Diagnostic Test

Compare optical coherence tomography lesion sizing and characteristics compared to traditional digital subtraction angiography

Primary outcomes

  1. Standardized Technique for OCT Use in the Lower Limb

    Time frame: 12 months

    To develop a protocolized, reproducible technique to maximize the Clear Image Length (CIL) on 75 mm pullbacks using 100% contrast in the tibial arteries. The goal is to compare intravascular ultrasound (IVUS) and optical coherence tomography (OCT) with traditional digital subtraction angiography (DSA) in determining best treatment strategy and vessel optimization, in an effort to improve long term patency and successful wound healing in CLI. The hypothesis is that the adjunctive use of intravascular imaging will affect vessel sizing and anticipated treatment modalities, and therein affect the long term primary patency rates.

Secondary outcomes

  1. Comparison of Percent Contrast

    Time frame: 12 months

    CIL in 100% contrast versus 50% contrast/heparinized saline mixture

  2. Vessel Characteristics: Minimal Lumen Area

    Time frame: 12 months

    minimal lumen area (mm^2)

  3. Vessel Characteristics: Reference Vessel Diameter

    Time frame: 12 months

    reference vessel diameter (mm)

  4. Vessel Characteristics: Reference Vessel Area

    Time frame: 12 months

    reference vessel area (mm^2)

  5. Vessel Characteristics: Percentage Stenosis

    Time frame: 12 months

    percentage stenosis (%) on pre-intervention imaging

  6. Plaque Characteristics: Morphology

    Time frame: 12 months

    Percentage composition of calcium, fibrous, or lipid plaque (%)

  7. Plaque Characteristics: Calcium Arc

    Time frame: 12 months

    Calcium arc (degree)

  8. Plaque Characteristics: Calcium Depth

    Time frame: 12 months

    depth of calcium (micron)

  9. Plaque Characteristics: Fibrous cap

    Time frame: 12 months

    depth of fibrous cap (micron)

  10. Attenuation

    Time frame: 12 months

    Measurement of attenuation coefficient (μ OCT) to quantify the strength of interaction of light and tissue

  11. Vessel Characteristics Following Intervention: Luminal Gain

    Time frame: 12 months

    Post-intervention luminal gain (%), plaque modification, and dissections

  12. Vessel Characteristics Following Intervention: Plaque Modification

    Time frame: 12 months

    Reduction in calcium depth (%) if atherectomy is performed

  13. Vessel Characteristics Following Intervention: Dissections

    Time frame: 12 months

    Qualitative description of dissections seen on post-intervention imaging

Sponsors and collaborators

Lead sponsor

University Hospitals Cleveland Medical Center

Other

Collaborators

  • Abbott Medical Devices

Registry information

Acronym: iVEST

Important dates

Study start
2021
Primary completion
2024
Study completion
2024
First posted
Feb 10, 2021
Registry last updated
May 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.